Microvi announced today that they were awarded a grant from the National Institute of Environmental Health Services (NIEHS) to develop a new technology for efficient, environmentally friendly, and cost-effective hexavalent chromium (Cr(VI)) treatment.
Read MoreAt the convention Microvi will be part of the Innovation Zone, a hub for the most promising biotech companies to exhibit their novel technologies. All of the companies in the zone have been competitively selected by the NIH or NSF to meet strict guidelines about their technologies and commercialization potential.
Read MoreThis follows on the success of work completed during the Phase I grant, where a prototype was developed and tested of a first-of-its-kind biological treatment technology for dioxane degradation called MB-DX™.
Read More